ANDA 86903, held by Epic Pharma LLC. Methylprednisolone Acetate.
As of Nov 16, 2026, ANDA 86903 (Methylprednisolone Acetate), held by Epic Pharma LLC, was not approved, with 0 approved supplements and 0 published complete response letters.
| Methylprednisolone Acetate40MG/ML · injectable;injection | Methylprednisolone Acetate | Discontinued |
| Methylprednisolone Acetate80MG/ML · injectable;injection | Methylprednisolone Acetate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters